Skip to main content

REVIEW article

Front. Pharmacol.
Sec. Neuropharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1428242
This article is part of the Research Topic Targeting Mitochondrial Dysfunction for the Discovery and Development of Novel CNS Therapies in Rare and Neurodegenerative Diseases View all articles

The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease

Provisionally accepted
Kassandra A. Zachos Kassandra A. Zachos 1Jann A. Gamboa Jann A. Gamboa 1Aleena S. Dewji Aleena S. Dewji 1Jocelyn Lee Jocelyn Lee 1Sonya Brijbassi Sonya Brijbassi 1Ana C. Andreazza Ana C. Andreazza 2*
  • 1 University of Toronto, Toronot, Canada
  • 2 University of Toronto, Toronto, Canada

The final, formatted version of the article will be published soon.

    The various roles of the mitochondria and the microbiome in health and disease have been thoroughly investigated, though they are often examined independently and in the context of chronic disease. However, the mitochondria and microbiome are closely connected, namely through their evolution, maternal inheritance patterns, overlapping role in many diseases and their importance in the maintenance of human health. The concept known as the ‘mitochondria-microbiome crosstalk’ is the ongoing bidirectional crosstalk between these two entities and warrants further exploration and consideration, especially in the context of primary mitochondrial disease, where mitochondrial dysfunction can be detrimental for clinical manifestation of disease, and the role and composition of the microbiome is rarely investigated. A potential mechanism underlying this crosstalk is the role of metabolites from both the mitochondria and the microbiome. During digestion, gut microbes modulate compounds found in food, which can produce metabolites with various bioactive effects. Similarly, mitochondrial metabolites are produced from substrates that undergo biochemical processes during cellular respiration. This review aims to provide an overview of current literature examining the mitochondria-microbiome crosstalk, the role of commonly studied metabolites serve in signaling and mediating these biochemical pathways, and the impact diet has on both the mitochondria and the microbiome. As a final point, this review highlights the up-to-date implications of the mitochondria – microbiome crosstalk in mitochondrial disease and its potential as a therapeutic tool or target.

    Keywords: Mitochondria, mitochondrial disease, microbiome, Mitochondria-microbiome crosstalk, Diet

    Received: 06 May 2024; Accepted: 10 Jul 2024.

    Copyright: © 2024 Zachos, Gamboa, Dewji, Lee, Brijbassi and Andreazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ana C. Andreazza, University of Toronto, Toronto, Canada

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.